In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MenoGeniX Inc.

Repurposed filgrastim for treating hot flashes

This article was originally published in Start Up

Executive Summary

MenoGeniX is developing a repurposed form of filgrastim as a non-hormonal treatment for menopausal symptoms, including hot flashes. Having achieved clinically meaningful results from its Phase 1b clinical trial, MenoGeniX’s goal is to find an industry partner or additional institutional investors to move the compound forward.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts